Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05217030 · ClinicalTrials.gov registry record · NA

Efficacy of Animal Assisted Therapy in the Treatment of Patients With Traumatic Brain Injury

A NA study, sponsored by Inova Health Care Services.

Completed
Registry status
NA
Development phase
70
Enrollment target

NCT05217030: Completed NA study, sponsored by Inova Health Care Services.

NCT05217030 is a NA study that has completed, run by Inova Health Care Services. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05217030, a NA study, has completed, sponsored by Inova Health Care Services.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target

Study Summary

Patients admitted to the ED with moderate to severe traumatic brain injury defined by GCS less than or equal to 10 and confirmed by head CT scan or MRI were randomized into 2 groups: one receiving animal assisted therapy (AAT) and one not receiving animal assisted therapy. Efficacy of AAT was measured by patient's progression in the Glasgow Coma Scale (GCS), Rancho Los Amigos Scale (RLAS), and ability to follow multi-step commands (LoCmds).

Primary Outcome

standard measure in acute care for level of consciousness with scale of 3 -15 and 15 being the higher level of consciousness

Interventions

  • OTHER Animal assisted therapy

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2014-06-30
Est. Completion 2019-12-31
Phase NA
Inova Health Care Services

75 total trials

What the finished NCT05217030 record still lists

NCT05217030 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Animal assisted therapy is the first listed.

NCT05217030 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05217030 about?

NCT05217030 is a clinical study titled "Efficacy of Animal Assisted Therapy in the Treatment of Patients With Traumatic Brain Injury". Patients admitted to the ED with moderate to severe traumatic brain injury defined by GCS less than or equal to 10 and confirmed by head CT scan or MRI were randomized into 2 groups: one receiving animal assisted therapy (AAT) and one not receiving animal assisted therapy. Efficacy of AAT was measur...

What is the current status of trial NCT05217030?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2014-06-30. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT05217030?

The interventions under investigation include: Animal assisted therapy (OTHER).

Who is sponsoring clinical trial NCT05217030?

This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05217030's enrollment target sits among peer trials

70 1103rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05217030, the US trial registry maintained by the National Library of Medicine. NCT05217030 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.